3 FDA Decisions to Look Out for in February Post author:Sam Post published:January 31, 2018 Post category:BioPharma Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace You Might Also Like Nativis, Inc. Convenes Inaugural Ultra-Low Radio Frequency Energy Technology Advisory Board (TAB) Meeting March 13, 2017 MD Anderson Cancer Center And BridgeBio Launch To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer October 3, 2017 Sanofi Genzyme Exec Exits to Become CMO of Flexion—Sanofi's Rumored Buyout Target April 6, 2017
Nativis, Inc. Convenes Inaugural Ultra-Low Radio Frequency Energy Technology Advisory Board (TAB) Meeting March 13, 2017
MD Anderson Cancer Center And BridgeBio Launch To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer October 3, 2017
Sanofi Genzyme Exec Exits to Become CMO of Flexion—Sanofi's Rumored Buyout Target April 6, 2017
